MedTrace Logo

The Application of Serum DNA Methylation for Patients With HCC

NCT05764551 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-03-21

No results posted yet for this study

Summary

The goal of this single-arm prospective study is to evaluate the application of serum DNA methylation for HCC patients with normal alpha-fetoprotein. The main question it aims to answer is

. Is the dynamic change of serum DNA methylation correlated to recurrence or treatment response of HCC

Conditions

Interventions

DIAGNOSTIC_TEST

Serum DNA methylation

Serum DNA methylation

Sponsors & Collaborators

  • Chiayi Christian Hospital

    lead OTHER

Principal Investigators

  • Po-Yueh Chen, M.D · Ditmanson Medical Foundation Chiayi Christian Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-28
Primary Completion
2025-03-31
Completion
2026-03-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05764551 on ClinicalTrials.gov